Dr. Martens (LON:DOCS) Shares Up 18.8% – Should You Buy?

Shares of Dr. Martens plc (LON:DOCS) rose 18.8% during mid-day trading on Thursday . The company traded as high as GBX 74.30 ($1.01) and last traded at GBX 71.25 ($0.97). Approximately 6,397,914 shares changed hands during mid-day trading, an increase of 186% from the average daily volume of 2,235,389 shares. The stock had previously closed at GBX 59.95 ($0.81).

Analyst Ratings Changes

Separately, Royal Bank of Canada cut their price target on Dr. Martens from GBX 7,000 ($94.86) to GBX 6,000 ($81.31) and set a “sector perform” rating for the company in a research note on Monday, May 19th.

Dr. Martens Price Performance

The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. The firm has a market cap of £716.91 million, a PE ratio of 10.47, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The stock has a 50 day simple moving average of GBX 54.24 and a 200-day simple moving average of GBX 62.52.

Dr. Martens (LON:DOCS) last issued its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Equities analysts anticipate that Dr. Martens plc will post 2.5809394 earnings per share for the current fiscal year.

Dr. Martens Cuts Dividend

The company also recently disclosed a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were given a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens’s payout ratio is 42.53%.

Insider Activity

In other news, insider Giles Wilson acquired 32,640 shares of the business’s stock in a transaction dated Tuesday, March 25th. The stock was purchased at an average price of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,886.16). Insiders bought a total of 33,206 shares of company stock worth $1,792,771 over the last 90 days. Corporate insiders own 4.36% of the company’s stock.

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.